Connect for Cancer Prevention Study (Connect)

计划入组 200,000 人 · 首次发布于 2020 年 10 月 30 日

Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL

首次发布于 2020 年 6 月 26 日

Neighborhood Connect

计划入组 240 人 · 首次发布于 2026 年 8 月 24 日

Encochleated amphotericin B (Matinas BioPharma)

NeuGene (AVI BioPharma)

Immune globulin (Therapure Biopharma)

CONNECT BIOPHARMA AUSTRALIA PTY LTD

Australia

Suzhou Connect Biopharmaceuticals Co., Ltd.

China

TAO Connect, Inc.

United States

Connect Biopharma Partners with Simcere for Rademikibart Development in Greater China

Simcere Submits New Drug Application for Rademikibart in China's 70 Million Patient Atopic Dermatitis Market

Rademikibart Shows Unprecedented 420mL Lung Function Improvement in Phase 2 Asthma Trial